FDA Warning Letter — Exxon

Case 494265 — FEI 3012243647

The FDA took a Warning Letter action against Exxon on Apr 14, 2016 (Mountainside, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Exxon
Date
Apr 14, 2016
Fiscal Year
2016
Product Type
Tobacco
Center
CTP
Location
Mountainside, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.